<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Orthop Surg Res</journal-id><journal-id journal-id-type="iso-abbrev">J Orthop Surg Res</journal-id><journal-id journal-id-type="pmc-domain-id">438</journal-id><journal-id journal-id-type="pmc-domain">jorthsurg</journal-id><journal-title-group><journal-title>Journal of Orthopaedic Surgery and Research</journal-title></journal-title-group><issn pub-type="epub">1749-799X</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11924824</article-id><article-id pub-id-type="pmcid-ver">PMC11924824.1</article-id><article-id pub-id-type="pmcaid">11924824</article-id><article-id pub-id-type="pmcaiid">11924824</article-id><article-id pub-id-type="pmid">40108610</article-id><article-id pub-id-type="doi">10.1186/s13018-025-05700-8</article-id><article-id pub-id-type="publisher-id">5700</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Impact of nicotine product use on outcomes of patients receiving cervical disc arthroplasty: a propensity score analysis of the united States nationwide inpatient sample 2005&#8211;2020</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Lin</surname><given-names initials="YJ">Yu-Jun</given-names></name><address><email>linyujun1022@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shih</surname><given-names initials="FY">Fu-Yuan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Huang</surname><given-names initials="JF">Jin-Fu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ting</surname><given-names initials="CW">Chun-Wei</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tsai</surname><given-names initials="YC">Yu-Chin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chang</surname><given-names initials="L">Lin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="HC">Hung-Cheng</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="WF">Wu-Fu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02verss31</institution-id><institution-id institution-id-type="GRID">grid.413801.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0711 0593</institution-id><institution>Department of Neurosurgery, </institution><institution>Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, </institution></institution-wrap>833301 No. 123, Ta-Pei Rd, Niao-Song Dist, Kaohsiung City, Taiwan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03db90279</institution-id><institution-id institution-id-type="GRID">grid.415007.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0477 6869</institution-id><institution>Department of Neurosurgery, </institution><institution>Kaohsiung Municipal Ta-Tung Hospital, </institution></institution-wrap>Kaohsiung City, Taiwan </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>3</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>20</volume><issue-id pub-id-type="pmc-issue-id">478198</issue-id><elocation-id>298</elocation-id><history><date date-type="received"><day>27</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>9</day><month>3</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>19</day><month>03</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>20</day><month>03</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-21 10:25:13.500"><day>21</day><month>03</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="13018_2025_Article_5700.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Nicotine product use, including cigarette smoking and other nicotine products, is a known risk factor for various health complications. While previous studies have examined its impact on spinal procedures, its specific effects on cervical disc arthroplasty (CDA) remain unclear. This study aims to investigate the association between nicotine product use and inpatient outcomes in patients undergoing CDA.</p></sec><sec><title>Methods</title><p id="Par2">Data from the 2005 to 2020 US Nationwide Inpatient Sample database of hospitalized adults&#8201;&#8805;&#8201;18 years old who underwent primary or revision CDA were extracted. Patients were divided into nicotine product users and non-users. Propensity score matching (PSM) was employed to balance the baseline characteristics between the groups. In-hospital mortality, unfavorable discharge, length of stay (LOS), and complications were compared between nicotine product users and non-users through logistic regression analyses.</p></sec><sec><title>Results</title><p id="Par3">After 1:1 PSM, 5,562 patients were included in the analysis. After adjustment, nicotine product users had a significantly elevated risk of overall complications (adjusted odds ratio [aOR]&#8201;=&#8201;1.37, 95% confidence interval [CI]: 1.13&#8211;1.66, <italic toggle="yes">p</italic>&#8201;=&#8201;0.002) and infection (aOR&#8201;=&#8201;1.74, 95% CI: 1.17&#8211;2.58, <italic toggle="yes">p</italic>&#8201;=&#8201;0.006). No significant association was observed between nicotine product use and the risk of unfavorable discharge or prolonged LOS (both, <italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05). In stratified analyses, male, but not female nicotine product users, had a greater risk of infection (aOR&#8201;=&#8201;2.12, 95% CI: 1.22&#8211;3.70, <italic toggle="yes">p</italic>&#8201;=&#8201;0.008). Nicotine product use was significantly associated with higher infection risk among individuals without diabetes, obesity, and chronic pulmonary disease (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05).</p></sec><sec><title>Conclusions</title><p id="Par4">Nicotine product use is associated with a higher risk of complications following CDA, particularly infections. The study highlights the importance of considering nicotine product use during preoperative assessments and postoperative care for patients undergoing CDA.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s13018-025-05700-8.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Nicotine product use</kwd><kwd>Cervical disc arthroplasty (CDA)</kwd><kwd>Nationwide inpatient sample (NIS)</kwd><kwd>In-hospital outcome</kwd><kwd>Propensity score matching (PSM)</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par5">Cervical disc degenerative disease is a prevalent health concern among older adults, characterized by the wear and tear of neck discs and associated with aging, genetics, occupational strain, prior neck injuries, osteoporosis, and smoking [<xref ref-type="bibr" rid="CR1">1</xref>&#8211;<xref ref-type="bibr" rid="CR3">3</xref>]. This condition impacts quality of life by causing chronic pain and limiting mobility, with treatment options ranging from pain management to surgical interventions [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par6">Cervical disc arthroplasty (CDA) has emerged as a preferred alternative to fusion, as it preserves neck mobility and reduces adjacent segment degeneration [<xref ref-type="bibr" rid="CR5">5</xref>]. CDA demonstrates outcomes comparable to or superior to anterior cervical arthrodesis, with a low complication rate of 1.5%. Common short-term complications include dysphagia, laryngeal nerve injury, Horner syndrome, and hematoma [<xref ref-type="bibr" rid="CR6">6</xref>]. Reoperation rates range from 1.8 to 5.4% after 5 years [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par7">Smoking is a significant global health concern, associated with 7.69&#160;million deaths and 200&#160;million disability-adjusted life-years in 2019 [<xref ref-type="bibr" rid="CR8">8</xref>]. Beyond respiratory conditions, smoking contributes to cardiovascular disease, greater susceptibility to respiratory infections, and adverse surgical outcomes [<xref ref-type="bibr" rid="CR9">9</xref>&#8211;<xref ref-type="bibr" rid="CR11">11</xref>]. Although the general health risks of smoking and nicotine product exposure are well-documented, its specific impact on cervical disc degenerative disease, particularly following CDA, remains unclear.</p><p id="Par8">Existing studies report mixed findings: smoking is associated with lower fusion rates and greater bone loss in hybrid cervical surgeries [<xref ref-type="bibr" rid="CR12">12</xref>], while other studies suggest no significant differences in clinical outcomes between smokers and non-smokers after CDA [<xref ref-type="bibr" rid="CR13">13</xref>]. Additionally, Lawand et al. explored non-tobacco nicotine use and its association with complications in anterior cervical discectomy and fusion, highlighting the diverse effects of nicotine products beyond traditional cigarette smoking [<xref ref-type="bibr" rid="CR14">14</xref>]. These conflicting findings reveal a significant knowledge gap regarding smoking and nicothine product exposure&#8217;s impact on postoperative outcomes in CDA patients.</p><p id="Par9">Given the rising adoption of CDA and the increasing use of nicotine products, a comprehensive evaluation of this relationship is crucial. Therefore, this study investigates the specific impact of nicotine product use on CDA outcomes using a large, nationally representative dataset from the United States.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Data source</title><p id="Par10">Data for this study were extracted from the 2005 to 2020 Nationwide Inpatient Sample (NIS), a database developed by the Healthcare Cost and Utilization Project (HCUP) in the US that is maintained by the Agency for Healthcare Research and Quality (AHRQ) [<xref ref-type="bibr" rid="CR15">15</xref>]. Details of the dataset can be accessed at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://hcup-us.ahrq.gov/nisoverview.jsp">https://hcup-us.ahrq.gov/nisoverview.jsp</ext-link>. The NIS database represents a 20% sample of inpatient admissions from 45 states and 1,051 hospitals that participated in collecting patient data at discharge. Principal and secondary diagnoses, principal and secondary procedures, admission date and diagnosis, discharge status, patient demographic data, and length of stay are included for each inpatient. Statistical weights that allow generalized estimates of national case volumes are also provided in the NIS.</p></sec><sec id="Sec4"><title>Study design and ethical considerations</title><p id="Par11">This was a population-based, retrospective study. This study complies with the terms of the NIS data-use agreement. The data utilized in this study were obtained through the Online HCUP Central Distributor. Given that this study solely involved the analysis of secondary data, there was no direct involvement of the general public or patients.</p></sec><sec id="Sec5"><title>Study population</title><p id="Par12">Hospitalized adults&#8201;&#8805;&#8201;18 years old who underwent either primary or revision CDA were included. Exclusion criteria were: (1) Cervical fracture; (2) Without recorded age and sex; and (3) Without sample weight value, outcomes of interest, and covariates. All diagnoses and procedures were identified by the International Classification of Diseases, Ninth Revision, and Tenth Revision, Clinical Modification (ICD-9-CM and ICD-10-CM) codes, as detailed in Supplemental Table <xref rid="MOESM1" ref-type="media">S1</xref>.</p></sec><sec id="Sec6"><title>Main outcomes and variables</title><p id="Par13">The outcomes of interest were in-hospital mortality, non-routine discharge (i.e., discharged to long-term care facilities), prolonged length of stay (LOS) (defined as &#8805;&#8201;75th LOS in the study sample), and complication rates. Complications included dysphagia, dysphonia, acute myocardial infarction (AMI), venous thromboembolism (VTE), cerebrovascular accident (CVA), pneumonia, sepsis, infection, respiratory failure, acute kidney injury (AKI), wound complications, complications of the nervous system, and complications of the digestive system.</p><p id="Par14">Demographic variables included patient age, sex, ethnicity (grouped into White, Black, Hispanic, and others), household income, insurance status (primary payer), and weekend admission. Admission type (emergency or elective) and year of admission were also included. Household income quartiles were obtained from the NIS, estimated from the household income of residents in the patient&#8217;s ZIP Code (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://hcup-us.ahrq.gov/db/vars/zipinc_qrtl/nisnote.jsp">https://hcup-us.ahrq.gov/db/vars/zipinc_qrtl/nisnote.jsp</ext-link>). Nicotine product use, hospital volume, and other relevant medical comorbidities were identified using ICD-9 and ICD-10 codes. Charlson Comorbidity Index (CCI) was calculated from individual comorbidities to represent patients&#8217; overall severity of comorbid conditions [<xref ref-type="bibr" rid="CR16">16</xref>]. Finally, hospital-related characteristics (bed size, location/teaching status, and hospital region) were also obtained as part of the comprehensive data available for all participants.</p></sec><sec id="Sec7"><title>Statistical analysis</title><p id="Par15">The HCUP-NIS database includes a 20% sample of US annual inpatient admissions, weighted samples (before 2011 using TRENDWT and after 2012 using DISCWT), stratum (NIS_STRATUM), and cluster (HOSPID) were used to produce national estimates for all analyses. The SURVEY procedure in SAS performs analysis for sample survey data. Patient descriptive statistics are presented as number (n) and weighted percentage (%), or mean and standard error (SE). Categorical data were analyzed by the PROC SURVEYFREQ statement and continuous data were analyzed by the PROC SURVEYREG statement. To minimize confounding, propensity score matching (PSM) was performed using a 1:1 ratio, with age (continuous), sex, ischemic heart disease, hypertension, diabetes, obesity, and chronic pulmonary disease as the matching variables. The matching process followed a one-to-many approach [<xref ref-type="bibr" rid="CR17">17</xref>]. PSM was chosen to minimize selection bias by balancing baseline characteristics before regression analysis, enhancing internal validity for a more accurate assessment of nicotine exposure and CDA outcomes. Logistic regression was then applied to the matched cohort for adjusted associations.</p><p id="Par16">The method prioritizes &#8220;best&#8221; matches first and then proceeds with &#8220;next-best&#8221; matches until no more can be made. Logistic regressions were performed using the PROC SURVEYLOGISTIC statement to determine the associations between study variables, in-hospital mortality, unfavorable discharge, prolonged LOS, and any complications, and results were reported as odds ratio (OR) and 95% confidence interval (CI). Multivariable regression was adjusted for variables that were significant (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) in the univariate analysis. Prolonged LOS was defined as a LOS&#8201;&#8805;&#8201;75th percentile of the study population. We applied the Benjamini-Hochberg (BH) procedure to control the false discovery rate (FDR). All p-values were 2-sided, and values of <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05 were considered statistically significant. All statistical analyses were performed using the statistical software package SAS software version 9.4 (SAS Institute Inc., Cary, NC, USA).</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Patient selection</title><p id="Par17">The patient selection process is depicted in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>. A total of 9,800 patients&#8201;&#8805;&#8201;18 years old who received primary or secondary CDA were identified in the 2005 to 2020 NIS database. Patients with missing information on sex, in-hospital mortality, and sample weight were excluded (<italic toggle="yes">n</italic>&#8201;=&#8201;45), as were 31 patients with fractures. Finally, 9,724 patients were included in the study, representing 47,978 hospitalized patients in the entire US after weighting, of which 2,781 were nicotine product users. After 1:1 PSM, 5,562 patients were included in the analysis, representing 27,438 hospitalized patients in the US.</p><p id="Par18">
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Flow diagram of patient selection</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e350" position="float" orientation="portrait" xlink:href="13018_2025_5700_Fig1_HTML.jpg"/></fig>
</p></sec><sec id="Sec10"><title>Patient characteristics before and after PSM</title><p id="Par19">Patient demographic characteristics, major comorbidities, and hospital-related characteristics are summarized in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>. Before PSM, the mean age of the study population was 47.5 years, 51.8% were females, and 79.8% were White. Compared to non-users of nicotine products, the nicotine product user group was notably younger, predominantly male and White, had lower income and were less frequently recipients of a fusion procedure. Additionally, the mean CCI was higher in the nicotine product user group compared to the non-user group. Specifically, 23.0% of nicotine product users had a CCI of 1 compared to 16.0% of non-users, while 5.7% of nicotine product users had a CCI of 2 compared to 4.0% of non-users, and 3.3% of nicotine product users had a CCI of 3&#8201;+&#8201;compared to 1.9% of non-users (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). Nicotine product users had a higher proportion of ischemic heart disease, hypertension, diabetes, obesity, and chronic pulmonary disease.</p><p id="Par20">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Characteristics of the study population</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="4" rowspan="1">Before PSM</th><th align="left" colspan="4" rowspan="1">After PSM</th></tr><tr><th align="left" colspan="1" rowspan="1">
<bold>Characteristics</bold>
</th><th align="left" colspan="1" rowspan="1">All patients<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;9,724)</th><th align="left" colspan="1" rowspan="1">Nicotine product use (<italic toggle="yes">n</italic>&#8201;=&#8201;2,781)</th><th align="left" colspan="1" rowspan="1">Non-use of nicotine products (<italic toggle="yes">n</italic>&#8201;=&#8201;6,943)</th><th align="left" colspan="1" rowspan="1">p-value</th><th align="left" colspan="1" rowspan="1">All patients<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;5,562)</th><th align="left" colspan="1" rowspan="1">Nicotine product use (<italic toggle="yes">n</italic>&#8201;=&#8201;2,781)</th><th align="left" colspan="1" rowspan="1">Non-use of nicotine products (<italic toggle="yes">n</italic>&#8201;=&#8201;2,781)</th><th align="left" colspan="1" rowspan="1">p-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">
<bold>Demography</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Age</bold>,<bold> years</bold></td><td align="left" colspan="1" rowspan="1">47.5&#8201;&#177;&#8201;0.1</td><td align="left" colspan="1" rowspan="1">47.1&#8201;&#177;&#8201;0.2</td><td align="left" colspan="1" rowspan="1">47.7&#8201;&#177;&#8201;0.2</td><td align="left" colspan="1" rowspan="1">
<bold>0.028</bold>
</td><td align="left" colspan="1" rowspan="1">46.9&#8201;&#177;&#8201;0.2</td><td align="left" colspan="1" rowspan="1">47.1&#8201;&#177;&#8201;0.2</td><td align="left" colspan="1" rowspan="1">46.7&#8201;&#177;&#8201;0.2</td><td align="left" colspan="1" rowspan="1">0.154</td></tr><tr><td align="left" colspan="1" rowspan="1">18&#8211;29</td><td align="left" colspan="1" rowspan="1">301 (3.1)</td><td align="left" colspan="1" rowspan="1">76 (2.7)</td><td align="left" colspan="1" rowspan="1">225 (3.2)</td><td align="left" colspan="1" rowspan="1">
<bold>0.002</bold>
</td><td align="left" colspan="1" rowspan="1">165 (3.0)</td><td align="left" colspan="1" rowspan="1">76 (2.7)</td><td align="left" colspan="1" rowspan="1">89 (3.2)</td><td align="left" colspan="1" rowspan="1">0.170</td></tr><tr><td align="left" colspan="1" rowspan="1">30&#8211;39</td><td align="left" colspan="1" rowspan="1">2,018 (20.8)</td><td align="left" colspan="1" rowspan="1">651 (23.4)</td><td align="left" colspan="1" rowspan="1">1,367 (19.7)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,290 (23.2)</td><td align="left" colspan="1" rowspan="1">651 (23.4)</td><td align="left" colspan="1" rowspan="1">639 (23.0)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">40&#8211;49</td><td align="left" colspan="1" rowspan="1">3,552 (36.6)</td><td align="left" colspan="1" rowspan="1">983 (35.3)</td><td align="left" colspan="1" rowspan="1">2,569 (37.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,993 (35.8)</td><td align="left" colspan="1" rowspan="1">983 (35.3)</td><td align="left" colspan="1" rowspan="1">1,010 (36.3)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">50&#8211;59</td><td align="left" colspan="1" rowspan="1">2,593 (26.6)</td><td align="left" colspan="1" rowspan="1">725 (26.1)</td><td align="left" colspan="1" rowspan="1">1,868 (26.9)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,477 (26.6)</td><td align="left" colspan="1" rowspan="1">725 (26.1)</td><td align="left" colspan="1" rowspan="1">752 (27.0)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">60&#8211;69</td><td align="left" colspan="1" rowspan="1">934 (9.6)</td><td align="left" colspan="1" rowspan="1">259 (9.3)</td><td align="left" colspan="1" rowspan="1">675 (9.7)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">481 (8.7)</td><td align="left" colspan="1" rowspan="1">259 (9.3)</td><td align="left" colspan="1" rowspan="1">222 (8.0)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">70+</td><td align="left" colspan="1" rowspan="1">326 (3.4)</td><td align="left" colspan="1" rowspan="1">87 (3.1)</td><td align="left" colspan="1" rowspan="1">239 (3.5)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">156 (2.8)</td><td align="left" colspan="1" rowspan="1">87 (3.1)</td><td align="left" colspan="1" rowspan="1">69 (2.5)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Sex</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.315</td></tr><tr><td align="left" colspan="1" rowspan="1">Male</td><td align="left" colspan="1" rowspan="1">4,686 (48.2)</td><td align="left" colspan="1" rowspan="1">1,435 (51.6)</td><td align="left" colspan="1" rowspan="1">3,251 (46.8)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">2,834 (51.0)</td><td align="left" colspan="1" rowspan="1">1,435 (51.6)</td><td align="left" colspan="1" rowspan="1">1,399 (50.3)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Female</td><td align="left" colspan="1" rowspan="1">5,038 (51.8)</td><td align="left" colspan="1" rowspan="1">1,346 (48.4)</td><td align="left" colspan="1" rowspan="1">3,692 (53.2)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">2,728 (49.0)</td><td align="left" colspan="1" rowspan="1">1,346 (48.4)</td><td align="left" colspan="1" rowspan="1">1,382 (49.7)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Race</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">White</td><td align="left" colspan="1" rowspan="1">7,150 (79.8)</td><td align="left" colspan="1" rowspan="1">2,129 (83.0)</td><td align="left" colspan="1" rowspan="1">5,021 (78.6)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">4,163 (81.1)</td><td align="left" colspan="1" rowspan="1">2,034 (79.2)</td><td align="left" colspan="1" rowspan="1">2,129 (83.0)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Black</td><td align="left" colspan="1" rowspan="1">647 (7.2)</td><td align="left" colspan="1" rowspan="1">160 (6.2)</td><td align="left" colspan="1" rowspan="1">487 (7.6)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">349 (6.8)</td><td align="left" colspan="1" rowspan="1">189 (7.4)</td><td align="left" colspan="1" rowspan="1">160 (6.2)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Hispanic</td><td align="left" colspan="1" rowspan="1">641 (7.2)</td><td align="left" colspan="1" rowspan="1">139 (5.4)</td><td align="left" colspan="1" rowspan="1">502 (7.9)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">339 (6.6)</td><td align="left" colspan="1" rowspan="1">200 (7.8)</td><td align="left" colspan="1" rowspan="1">139 (5.4)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Other</td><td align="left" colspan="1" rowspan="1">518 (5.8)</td><td align="left" colspan="1" rowspan="1">136 (5.3)</td><td align="left" colspan="1" rowspan="1">382 (6.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">279 (5.4)</td><td align="left" colspan="1" rowspan="1">143 (5.6)</td><td align="left" colspan="1" rowspan="1">136 (5.3)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Missing</td><td align="left" colspan="1" rowspan="1">768</td><td align="left" colspan="1" rowspan="1">217</td><td align="left" colspan="1" rowspan="1">551</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">432</td><td align="left" colspan="1" rowspan="1">217</td><td align="left" colspan="1" rowspan="1">215</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Income</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Q1</td><td align="left" colspan="1" rowspan="1">1,718 (18.3)</td><td align="left" colspan="1" rowspan="1">586 (21.7)</td><td align="left" colspan="1" rowspan="1">1,132 (16.9)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,048 (19.5)</td><td align="left" colspan="1" rowspan="1">586 (21.7)</td><td align="left" colspan="1" rowspan="1">462 (17.3)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Q2</td><td align="left" colspan="1" rowspan="1">2,245 (23.9)</td><td align="left" colspan="1" rowspan="1">712 (26.5)</td><td align="left" colspan="1" rowspan="1">1,533 (22.9)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,316 (24.5)</td><td align="left" colspan="1" rowspan="1">712 (26.5)</td><td align="left" colspan="1" rowspan="1">604 (22.5)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Q3</td><td align="left" colspan="1" rowspan="1">2,536 (27.0)</td><td align="left" colspan="1" rowspan="1">755 (27.9)</td><td align="left" colspan="1" rowspan="1">1,781 (26.6)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,495 (27.7)</td><td align="left" colspan="1" rowspan="1">755 (27.9)</td><td align="left" colspan="1" rowspan="1">740 (27.5)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Q4</td><td align="left" colspan="1" rowspan="1">2,889 (30.8)</td><td align="left" colspan="1" rowspan="1">644 (23.9)</td><td align="left" colspan="1" rowspan="1">2,245 (33.6)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,521 (28.3)</td><td align="left" colspan="1" rowspan="1">644 (23.9)</td><td align="left" colspan="1" rowspan="1">877 (32.7)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Missing</td><td align="left" colspan="1" rowspan="1">336</td><td align="left" colspan="1" rowspan="1">84</td><td align="left" colspan="1" rowspan="1">252</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">182</td><td align="left" colspan="1" rowspan="1">84</td><td align="left" colspan="1" rowspan="1">98</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Insurance status / Primary Payer</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Medicare / Medicaid</td><td align="left" colspan="1" rowspan="1">1,838 (19.0)</td><td align="left" colspan="1" rowspan="1">737 (26.6)</td><td align="left" colspan="1" rowspan="1">1,101 (15.9)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,154 (20.8)</td><td align="left" colspan="1" rowspan="1">737 (26.6)</td><td align="left" colspan="1" rowspan="1">417 (15.0)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Private including HMO</td><td align="left" colspan="1" rowspan="1">6,038 (62.2)</td><td align="left" colspan="1" rowspan="1">1,514 (54.5)</td><td align="left" colspan="1" rowspan="1">4,524 (65.3)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">3,368 (60.6)</td><td align="left" colspan="1" rowspan="1">1,514 (54.5)</td><td align="left" colspan="1" rowspan="1">1,854 (66.8)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Self-pay / No charge / Other</td><td align="left" colspan="1" rowspan="1">1,830 (18.8)</td><td align="left" colspan="1" rowspan="1">524 (18.9)</td><td align="left" colspan="1" rowspan="1">1,306 (18.8)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,030 (18.5)</td><td align="left" colspan="1" rowspan="1">524 (18.9)</td><td align="left" colspan="1" rowspan="1">506 (18.2)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Missing</td><td align="left" colspan="1" rowspan="1">18</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">12</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Admission type</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.721</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.549</td></tr><tr><td align="left" colspan="1" rowspan="1">Elective</td><td align="left" colspan="1" rowspan="1">8,616 (88.8)</td><td align="left" colspan="1" rowspan="1">2,470 (89.0)</td><td align="left" colspan="1" rowspan="1">6,146 (88.8)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">4,953 (89.3)</td><td align="left" colspan="1" rowspan="1">2,470 (89.0)</td><td align="left" colspan="1" rowspan="1">2,483 (89.5)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Emergent</td><td align="left" colspan="1" rowspan="1">1,080 (11.2)</td><td align="left" colspan="1" rowspan="1">304 (11.0)</td><td align="left" colspan="1" rowspan="1">776 (11.2)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">594 (10.7)</td><td align="left" colspan="1" rowspan="1">304 (11.0)</td><td align="left" colspan="1" rowspan="1">290 (10.5)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Missing</td><td align="left" colspan="1" rowspan="1">28</td><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">21</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">15</td><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Receiving cervical spine fusion</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.056</td></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">8,026 (82.8)</td><td align="left" colspan="1" rowspan="1">2,363 (85.2)</td><td align="left" colspan="1" rowspan="1">5,663 (81.8)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">4,670 (84.2)</td><td align="left" colspan="1" rowspan="1">2,363 (85.2)</td><td align="left" colspan="1" rowspan="1">2,307 (83.2)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">1,698 (17.2)</td><td align="left" colspan="1" rowspan="1">418 (14.8)</td><td align="left" colspan="1" rowspan="1">1,280 (18.2)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">892 (15.8)</td><td align="left" colspan="1" rowspan="1">418 (14.8)</td><td align="left" colspan="1" rowspan="1">474 (16.8)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Year of Admission</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">2005&#8211;2008</td><td align="left" colspan="1" rowspan="1">1,300 (12.7)</td><td align="left" colspan="1" rowspan="1">330 (11.3)</td><td align="left" colspan="1" rowspan="1">970 (13.2)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">724 (12.4)</td><td align="left" colspan="1" rowspan="1">330 (11.3)</td><td align="left" colspan="1" rowspan="1">394 (13.4)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">2009&#8211;2012</td><td align="left" colspan="1" rowspan="1">2,426 (24.8)</td><td align="left" colspan="1" rowspan="1">651 (23.2)</td><td align="left" colspan="1" rowspan="1">1,775 (25.5)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,369 (24.4)</td><td align="left" colspan="1" rowspan="1">651 (23.2)</td><td align="left" colspan="1" rowspan="1">718 (25.7)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">2013&#8211;2016</td><td align="left" colspan="1" rowspan="1">2,865 (29.9)</td><td align="left" colspan="1" rowspan="1">795 (28.9)</td><td align="left" colspan="1" rowspan="1">2,070 (30.2)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,640 (29.9)</td><td align="left" colspan="1" rowspan="1">795 (28.9)</td><td align="left" colspan="1" rowspan="1">845 (30.8)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">2017&#8211;2020</td><td align="left" colspan="1" rowspan="1">3,133 (32.7)</td><td align="left" colspan="1" rowspan="1">1,005 (36.6)</td><td align="left" colspan="1" rowspan="1">2,128 (31.1)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,829 (33.3)</td><td align="left" colspan="1" rowspan="1">1,005 (36.6)</td><td align="left" colspan="1" rowspan="1">824 (30.1)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Major comorbidities</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Ischemic heart disease</td><td align="left" colspan="1" rowspan="1">381 (3.9)</td><td align="left" colspan="1" rowspan="1">141 (5.1)</td><td align="left" colspan="1" rowspan="1">240 (3.4)</td><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1">268 (4.8)</td><td align="left" colspan="1" rowspan="1">141 (5.1)</td><td align="left" colspan="1" rowspan="1">127 (4.6)</td><td align="left" colspan="1" rowspan="1">0.364</td></tr><tr><td align="left" colspan="1" rowspan="1">Atrial fibrillation</td><td align="left" colspan="1" rowspan="1">94 (1.0)</td><td align="left" colspan="1" rowspan="1">25 (0.9)</td><td align="left" colspan="1" rowspan="1">69 (1.0)</td><td align="left" colspan="1" rowspan="1">0.740</td><td align="left" colspan="1" rowspan="1">53 (0.9)</td><td align="left" colspan="1" rowspan="1">25 (0.9)</td><td align="left" colspan="1" rowspan="1">28 (1.0)</td><td align="left" colspan="1" rowspan="1">0.786</td></tr><tr><td align="left" colspan="1" rowspan="1">Hypertension</td><td align="left" colspan="1" rowspan="1">2862 (29.4)</td><td align="left" colspan="1" rowspan="1">898 (32.3)</td><td align="left" colspan="1" rowspan="1">1964 (28.2)</td><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1">1,791 (32.2)</td><td align="left" colspan="1" rowspan="1">898 (32.3)</td><td align="left" colspan="1" rowspan="1">893 (32.0)</td><td align="left" colspan="1" rowspan="1">0.801</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes</td><td align="left" colspan="1" rowspan="1">966 (10.0)</td><td align="left" colspan="1" rowspan="1">315 (11.4)</td><td align="left" colspan="1" rowspan="1">651 (9.4)</td><td align="left" colspan="1" rowspan="1">
<bold>0.002</bold>
</td><td align="left" colspan="1" rowspan="1">618 (11.1)</td><td align="left" colspan="1" rowspan="1">315 (11.4)</td><td align="left" colspan="1" rowspan="1">303 (10.9)</td><td align="left" colspan="1" rowspan="1">0.537</td></tr><tr><td align="left" colspan="1" rowspan="1">Obesity</td><td align="left" colspan="1" rowspan="1">1,123 (11.6)</td><td align="left" colspan="1" rowspan="1">370 (13.4)</td><td align="left" colspan="1" rowspan="1">753 (10.9)</td><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1">736 (13.3)</td><td align="left" colspan="1" rowspan="1">370 (13.4)</td><td align="left" colspan="1" rowspan="1">366 (13.1)</td><td align="left" colspan="1" rowspan="1">0.728</td></tr><tr><td align="left" colspan="1" rowspan="1">Chronic pulmonary disease</td><td align="left" colspan="1" rowspan="1">1,233 (12.7)</td><td align="left" colspan="1" rowspan="1">520 (18.8)</td><td align="left" colspan="1" rowspan="1">713 (10.2)</td><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1">1,041 (18.7)</td><td align="left" colspan="1" rowspan="1">520 (18.8)</td><td align="left" colspan="1" rowspan="1">521 (18.7)</td><td align="left" colspan="1" rowspan="1">0.893</td></tr><tr><td align="left" colspan="1" rowspan="1">Chronic kidney disease</td><td align="left" colspan="1" rowspan="1">113 (1.2)</td><td align="left" colspan="1" rowspan="1">35 (1.3)</td><td align="left" colspan="1" rowspan="1">78 (1.1)</td><td align="left" colspan="1" rowspan="1">0.548</td><td align="left" colspan="1" rowspan="1">69 (1.3)</td><td align="left" colspan="1" rowspan="1">35 (1.3)</td><td align="left" colspan="1" rowspan="1">34 (1.2)</td><td align="left" colspan="1" rowspan="1">0.924</td></tr><tr><td align="left" colspan="1" rowspan="1">Rheumatic disease</td><td align="left" colspan="1" rowspan="1">137 (1.4)</td><td align="left" colspan="1" rowspan="1">46 (1.7)</td><td align="left" colspan="1" rowspan="1">91 (1.3)</td><td align="left" colspan="1" rowspan="1">0.184</td><td align="left" colspan="1" rowspan="1">90 (1.6)</td><td align="left" colspan="1" rowspan="1">46 (1.7)</td><td align="left" colspan="1" rowspan="1">44 (1.6)</td><td align="left" colspan="1" rowspan="1">0.809</td></tr><tr><td align="left" colspan="1" rowspan="1">Any malignancy</td><td align="left" colspan="1" rowspan="1">36 (0.4)</td><td align="left" colspan="1" rowspan="1">13 (0.5)</td><td align="left" colspan="1" rowspan="1">23 (0.3)</td><td align="left" colspan="1" rowspan="1">0.245</td><td align="left" colspan="1" rowspan="1">19 (0.3)</td><td align="left" colspan="1" rowspan="1">13 (0.5)</td><td align="left" colspan="1" rowspan="1">6 (0.2)</td><td align="left" colspan="1" rowspan="1">0.091</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Charlson comorbidity index</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.118</td></tr><tr><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">7,316 (75.2)</td><td align="left" colspan="1" rowspan="1">1,893 (67.9)</td><td align="left" colspan="1" rowspan="1">5,423 (78.1)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">3,827 (68.8)</td><td align="left" colspan="1" rowspan="1">1,893 (67.9)</td><td align="left" colspan="1" rowspan="1">1,934 (69.6)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">1,754 (18.0)</td><td align="left" colspan="1" rowspan="1">639 (23.0)</td><td align="left" colspan="1" rowspan="1">1115 (16.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,264 (22.7)</td><td align="left" colspan="1" rowspan="1">639 (23.0)</td><td align="left" colspan="1" rowspan="1">625 (22.4)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">435 (4.5)</td><td align="left" colspan="1" rowspan="1">159 (5.7)</td><td align="left" colspan="1" rowspan="1">276 (4.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">316 (5.7)</td><td align="left" colspan="1" rowspan="1">159 (5.7)</td><td align="left" colspan="1" rowspan="1">157 (5.7)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">3+</td><td align="left" colspan="1" rowspan="1">219 (2.3)</td><td align="left" colspan="1" rowspan="1">90 (3.3)</td><td align="left" colspan="1" rowspan="1">129 (1.9)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">155 (2.8)</td><td align="left" colspan="1" rowspan="1">90 (3.3)</td><td align="left" colspan="1" rowspan="1">65 (2.3)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Hospital bed size</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.334</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.558</td></tr><tr><td align="left" colspan="1" rowspan="1">Small</td><td align="left" colspan="1" rowspan="1">1,887 (19.3)</td><td align="left" colspan="1" rowspan="1">511 (18.4)</td><td align="left" colspan="1" rowspan="1">1,376 (19.7)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,057 (18.9)</td><td align="left" colspan="1" rowspan="1">511 (18.4)</td><td align="left" colspan="1" rowspan="1">546 (19.5)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Medium</td><td align="left" colspan="1" rowspan="1">2,615 (27.0)</td><td align="left" colspan="1" rowspan="1">771 (27.7)</td><td align="left" colspan="1" rowspan="1">1,844 (26.7)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,518 (27.4)</td><td align="left" colspan="1" rowspan="1">771 (27.7)</td><td align="left" colspan="1" rowspan="1">747 (27.1)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Large</td><td align="left" colspan="1" rowspan="1">5,189 (53.7)</td><td align="left" colspan="1" rowspan="1">1,492 (54.0)</td><td align="left" colspan="1" rowspan="1">3,697 (53.5)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">2,969 (53.7)</td><td align="left" colspan="1" rowspan="1">1,492 (54.0)</td><td align="left" colspan="1" rowspan="1">1,477 (53.4)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Missing</td><td align="left" colspan="1" rowspan="1">33</td><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">26</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">18</td><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">11</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Location / Teaching status</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Rural</td><td align="left" colspan="1" rowspan="1">342 (3.6)</td><td align="left" colspan="1" rowspan="1">126 (4.5)</td><td align="left" colspan="1" rowspan="1">216 (3.2)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">200 (3.6)</td><td align="left" colspan="1" rowspan="1">126 (4.5)</td><td align="left" colspan="1" rowspan="1">74 (2.7)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Urban nonteaching</td><td align="left" colspan="1" rowspan="1">3,545 (36.4)</td><td align="left" colspan="1" rowspan="1">923 (33.1)</td><td align="left" colspan="1" rowspan="1">2,622 (37.8)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,975 (35.5)</td><td align="left" colspan="1" rowspan="1">923 (33.1)</td><td align="left" colspan="1" rowspan="1">1,052 (37.8)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Urban teaching</td><td align="left" colspan="1" rowspan="1">5,804 (60.0)</td><td align="left" colspan="1" rowspan="1">1,725 (62.3)</td><td align="left" colspan="1" rowspan="1">4079 (59.1)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">3,369 (60.9)</td><td align="left" colspan="1" rowspan="1">1,725 (62.3)</td><td align="left" colspan="1" rowspan="1">1,644 (59.4)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Missing</td><td align="left" colspan="1" rowspan="1">33</td><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">26</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">18</td><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">11</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Hospital region</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Northeast</td><td align="left" colspan="1" rowspan="1">1,633 (16.9)</td><td align="left" colspan="1" rowspan="1">471 (17.0)</td><td align="left" colspan="1" rowspan="1">1,162 (16.8)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">930 (16.8)</td><td align="left" colspan="1" rowspan="1">471 (17.0)</td><td align="left" colspan="1" rowspan="1">459 (16.6)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Midwest</td><td align="left" colspan="1" rowspan="1">1,861 (19.2)</td><td align="left" colspan="1" rowspan="1">634 (22.9)</td><td align="left" colspan="1" rowspan="1">1,227 (17.7)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,124 (20.3)</td><td align="left" colspan="1" rowspan="1">634 (22.9)</td><td align="left" colspan="1" rowspan="1">490 (17.7)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">South</td><td align="left" colspan="1" rowspan="1">3,305 (33.8)</td><td align="left" colspan="1" rowspan="1">913 (32.7)</td><td align="left" colspan="1" rowspan="1">2,392 (34.2)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,875 (33.5)</td><td align="left" colspan="1" rowspan="1">913 (32.7)</td><td align="left" colspan="1" rowspan="1">962 (34.4)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">West</td><td align="left" colspan="1" rowspan="1">2,925 (30.2)</td><td align="left" colspan="1" rowspan="1">763 (27.5)</td><td align="left" colspan="1" rowspan="1">2,162 (31.2)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1,633 (29.4)</td><td align="left" colspan="1" rowspan="1">763 (27.5)</td><td align="left" colspan="1" rowspan="1">870 (31.4)</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p>Abbreviations: PSM, propensity score matching; AMI, acute myocardial infarction; CVA, cerebral vascular accident; VTE, venous thromboembolism</p><p>Continuous data are presented as mean&#8201;&#177;&#8201;SE; categorical data are presented as unweighted counts (weighted percentage)</p><p>p-values&#8201;&lt;&#8201;0.05 are shown in bold</p></table-wrap-foot></table-wrap>
</p><p id="Par21">After PSM, significant differences between the 2 groups remained concerning race, income, insurance status/primary payer, year of admission, location/teaching status of the hospital, and hospital region (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>).</p></sec><sec id="Sec11"><title>Inpatient outcomes after PSM</title><p id="Par22">The outcomes after PSM are summarized in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>. Compared to non-users of nicotine products, those who used nicotine products had a significantly higher percentage of any complications (9.6% vs. 7.0%, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), as well as cardio-cerebrovascular events (i.e., AMI or CVA) (0.6% vs. 0.3%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.026), and infection (2.9% vs. 1.5%, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001).</p><p id="Par23">
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>In-hospital outcomes of the study population after PSM</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">All patients<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;5,562)</th><th align="left" colspan="1" rowspan="1">Nicotine product use (<italic toggle="yes">n</italic>&#8201;=&#8201;2,781)</th><th align="left" colspan="1" rowspan="1">Non-use of nicotine products (<italic toggle="yes">n</italic>&#8201;=&#8201;2,781)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">
<bold>Outcomes</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>In-hospital mortality</bold>
</td><td char="." align="char" colspan="1" rowspan="1">5 (0.1)</td><td char="." align="char" colspan="1" rowspan="1">3 (0.1)</td><td char="." align="char" colspan="1" rowspan="1">2 (0.1)</td><td char="." align="char" colspan="1" rowspan="1">0.555</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Unfavorable discharge</bold>
<sup><bold>a</bold></sup>
</td><td char="." align="char" colspan="1" rowspan="1">141 (2.6)</td><td char="." align="char" colspan="1" rowspan="1">78 (2.8)</td><td char="." align="char" colspan="1" rowspan="1">63 (2.3)</td><td char="." align="char" colspan="1" rowspan="1">0.158</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Prolonged LOS</bold>
<sup><bold>a, b</bold></sup>
</td><td char="." align="char" colspan="1" rowspan="1">726 (13.0)</td><td char="." align="char" colspan="1" rowspan="1">380 (13.7)</td><td char="." align="char" colspan="1" rowspan="1">346 (12.4)</td><td char="." align="char" colspan="1" rowspan="1">0.163</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Any complications</bold>
</td><td char="." align="char" colspan="1" rowspan="1">485 (8.7)</td><td char="." align="char" colspan="1" rowspan="1">278 (10.0)</td><td char="." align="char" colspan="1" rowspan="1">207 (7.4)</td><td char="." align="char" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Dysphagia</td><td char="." align="char" colspan="1" rowspan="1">223 (4.0)</td><td char="." align="char" colspan="1" rowspan="1">118 (4.2)</td><td char="." align="char" colspan="1" rowspan="1">105 (3.8)</td><td char="." align="char" colspan="1" rowspan="1">0.324</td></tr><tr><td align="left" colspan="1" rowspan="1">Dysphonia</td><td char="." align="char" colspan="1" rowspan="1">12 (0.2)</td><td char="." align="char" colspan="1" rowspan="1">6 (0.2)</td><td char="." align="char" colspan="1" rowspan="1">6 (0.2)</td><td char="." align="char" colspan="1" rowspan="1">0.975</td></tr><tr><td align="left" colspan="1" rowspan="1">AMI or CVA</td><td char="." align="char" colspan="1" rowspan="1">24 (0.4)</td><td char="." align="char" colspan="1" rowspan="1">16 (0.6)</td><td char="." align="char" colspan="1" rowspan="1">8 (0.3)</td><td char="." align="char" colspan="1" rowspan="1">
<bold>0.026</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">VTE</td><td char="." align="char" colspan="1" rowspan="1">16 (0.3)</td><td char="." align="char" colspan="1" rowspan="1">9 (0.3)</td><td char="." align="char" colspan="1" rowspan="1">7 (0.3)</td><td char="." align="char" colspan="1" rowspan="1">0.623</td></tr><tr><td align="left" colspan="1" rowspan="1">Pneumonia</td><td char="." align="char" colspan="1" rowspan="1">22 (0.4)</td><td char="." align="char" colspan="1" rowspan="1">14 (0.5)</td><td char="." align="char" colspan="1" rowspan="1">8 (0.3)</td><td char="." align="char" colspan="1" rowspan="1">0.125</td></tr><tr><td align="left" colspan="1" rowspan="1">Sepsis</td><td char="." align="char" colspan="1" rowspan="1">18 (0.3)</td><td char="." align="char" colspan="1" rowspan="1">9 (0.4)</td><td char="." align="char" colspan="1" rowspan="1">9 (0.3)</td><td char="." align="char" colspan="1" rowspan="1">0.793</td></tr><tr><td align="left" colspan="1" rowspan="1">Infection</td><td char="." align="char" colspan="1" rowspan="1">120 (2.2)</td><td char="." align="char" colspan="1" rowspan="1">79 (2.9)</td><td char="." align="char" colspan="1" rowspan="1">41 (1.5)</td><td char="." align="char" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">SSI</td><td char="." align="char" colspan="1" rowspan="1">4 (0.1)</td><td char="." align="char" colspan="1" rowspan="1">1 (0.03)</td><td char="." align="char" colspan="1" rowspan="1">3 (0.1)</td><td char="." align="char" colspan="1" rowspan="1">0.316</td></tr><tr><td align="left" colspan="1" rowspan="1">UTI</td><td char="." align="char" colspan="1" rowspan="1">36 (0.7)</td><td char="." align="char" colspan="1" rowspan="1">20 (0.7)</td><td char="." align="char" colspan="1" rowspan="1">16 (0.6)</td><td char="." align="char" colspan="1" rowspan="1">0.432</td></tr><tr><td align="left" colspan="1" rowspan="1">Hemorrhage/hematoma</td><td char="." align="char" colspan="1" rowspan="1">19 (0.3)</td><td char="." align="char" colspan="1" rowspan="1">10 (0.4)</td><td char="." align="char" colspan="1" rowspan="1">9 (0.3)</td><td char="." align="char" colspan="1" rowspan="1">0.768</td></tr><tr><td align="left" colspan="1" rowspan="1">Respiratory failure/Mechanical ventilation</td><td char="." align="char" colspan="1" rowspan="1">69 (1.2)</td><td char="." align="char" colspan="1" rowspan="1">41 (1.5)</td><td char="." align="char" colspan="1" rowspan="1">28 (1.0)</td><td char="." align="char" colspan="1" rowspan="1">0.075</td></tr><tr><td align="left" colspan="1" rowspan="1">AKI</td><td char="." align="char" colspan="1" rowspan="1">22 (0.4)</td><td char="." align="char" colspan="1" rowspan="1">8 (0.3)</td><td char="." align="char" colspan="1" rowspan="1">14 (0.5)</td><td char="." align="char" colspan="1" rowspan="1">0.166</td></tr><tr><td align="left" colspan="1" rowspan="1">Wound complication</td><td char="." align="char" colspan="1" rowspan="1">9 (0.2)</td><td char="." align="char" colspan="1" rowspan="1">6 (0.2)</td><td char="." align="char" colspan="1" rowspan="1">3 (0.1)</td><td char="." align="char" colspan="1" rowspan="1">0.295</td></tr><tr><td align="left" colspan="1" rowspan="1">Nervous system complication</td><td char="." align="char" colspan="1" rowspan="1">21 (0.4)</td><td char="." align="char" colspan="1" rowspan="1">12 (0.4)</td><td char="." align="char" colspan="1" rowspan="1">9 (0.3)</td><td char="." align="char" colspan="1" rowspan="1">0.493</td></tr><tr><td align="left" colspan="1" rowspan="1">Digestive system complication</td><td char="." align="char" colspan="1" rowspan="1">5 (0.1)</td><td char="." align="char" colspan="1" rowspan="1">2 (0.1)</td><td char="." align="char" colspan="1" rowspan="1">3 (0.1)</td><td char="." align="char" colspan="1" rowspan="1">0.742</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: AMI, acute myocardial infarction; AKI, acute kidney injury; CVA, cerebrovascular accident; VTE, venous thromboembolism; SSI, surgical site infection; UTI, urinary tract infection; PSM, propensity score matching; LOS, length of hospital stay</p><p>Categorical variables are presented as unweighted counts (weighted percentages)</p><p><sup>a</sup> Excluding patients who died in the hospital. <sup>b</sup> LOS&#8201;&gt;&#8201;75th percentile: 2 days</p><p>p-values&#8201;&lt;&#8201;0.05 shown in bold</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec12"><title>Associations between nicotine product use and inpatient outcomes</title><p id="Par24">Table&#160;<xref rid="Tab3" ref-type="table">3</xref> shows the associations between nicotine product use and outcomes. After adjustment in the multivariable analysis, we found that nicotine product users had a significantly higher risk for any complications (adjusted odds ratio [aOR]&#8201;=&#8201;1.37, 95% CI: 1.13&#8211;1.66, <italic toggle="yes">p</italic>&#8201;=&#8201;0.002) compared to non-users. In addition, nicotine product users also had a significantly higher risk of infection (aOR&#8201;=&#8201;1.74, 95% CI: 1.17&#8211;2.58, <italic toggle="yes">p</italic>&#8201;=&#8201;0.006) compared to non-users. Nicotine product use was not significantly associated with unfavorable discharge or prolonged LOS (both, <italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05) (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>).</p><p id="Par25">
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Associations between smoking and inpatient outcomes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Outcomes</th><th align="left" colspan="1" rowspan="1">Nicotine product use</th><th align="left" colspan="1" rowspan="1">OR (95% CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th><th align="left" colspan="1" rowspan="1">aOR (95% CI)</th><th align="left" colspan="2" rowspan="1"><italic toggle="yes">p</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">
<bold>Unfavorable discharge</bold>
<sup><bold>a</bold>, <bold>e</bold></sup>
</td><td align="left" colspan="1" rowspan="1">Yes vs. No</td><td align="left" colspan="1" rowspan="1">1.26 (0.91&#8211;1.73)</td><td align="left" colspan="1" rowspan="1">0.160</td><td align="left" colspan="1" rowspan="1">1.27 (0.86&#8211;1.87)</td><td align="left" colspan="2" rowspan="1">0.239</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Prolonged LOS</bold>
<sup><bold>b, e, f</bold></sup>
</td><td align="left" colspan="1" rowspan="1">Yes vs. No</td><td align="left" colspan="1" rowspan="1">1.11 (0.96&#8211;1.30)</td><td align="left" colspan="1" rowspan="1">0.164</td><td align="left" colspan="2" rowspan="1">1.07 (0.90&#8211;1.28)</td><td align="left" colspan="1" rowspan="1">0.449</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Any complications</bold>
<sup><bold>c</bold></sup>
</td><td align="left" colspan="1" rowspan="1">Yes vs. No</td><td align="left" colspan="1" rowspan="1">1.39 (1.17&#8211;1.67)</td><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1">1.37 (1.13&#8211;1.66)</td><td align="left" colspan="2" rowspan="1">
<bold>0.002</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Infection</bold>
<sup><bold>d</bold></sup>
</td><td align="left" colspan="1" rowspan="1">Yes vs. No</td><td align="left" colspan="1" rowspan="1">1.96 (1.36&#8211;2.83)</td><td align="left" colspan="1" rowspan="1">
<bold>&lt;&#8201;0.001</bold>
</td><td align="left" colspan="1" rowspan="1">1.74 (1.17&#8211;2.58)</td><td align="left" colspan="2" rowspan="1">
<bold>0.006</bold>
</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: LOS, length of hospital stay; OR, odds ratio; aOR, adjusted OR; CI, confidence interval; CCI, Charlson comorbidity index</p><p>p-values&#8201;&lt;&#8201;0.05 are shown in bold</p><p><sup>a</sup> Adjusted for variables that were significant (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) in the univariate analysis (except for CCI), including age (continuous), race, insurance status / primary payer, admission type, admission type, receiving cervical spine fusion, ischemic heart disease, atrial fibrillation, hypertension, diabetes, chronic pulmonary disease, chronic kidney disease, rheumatic disease, any malignancy, hospital bed size, and location / teaching status</p><p><sup>b</sup> Adjusted for significant variables (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) in the univariate analysis (except for CCI), including age (continuous), race, income, insurance status / primary payer, admission type, receiving cervical spine fusion, ischemic heart disease, atrial fibrillation, hypertension, diabetes, obesity, chronic pulmonary disease, chronic kidney disease, any malignancy, hospital bed size, and location / teaching status</p><p><sup>c</sup> Adjusted for significant variables (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) in the univariate analysis (except for CCI), including age (continuous), race, insurance status / primary payer, admission type, receiving cervical spine fusion, ischemic heart disease, atrial fibrillation, hypertension, diabetes, obesity, chronic pulmonary disease, chronic kidney disease, rheumatic disease, any malignancy, and location / teaching status</p><p><sup>d</sup> Adjusted for variables that were significant (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) in the univariate analysis (except for CCI), including age (continuous), income, insurance status / primary payer, admission type, hypertension, diabetes, chronic pulmonary disease, chronic kidney disease, rheumatic disease, any malignancy, and location / teaching status</p><p><sup>e</sup> Excluding patients who died in the hospital</p><p><sup>f</sup> LOS&#8201;&gt;&#8201;75th percentile: 2 days</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec112"><title>Associations between nicotine product use and outcomes stratified by sex, diabetes, obesity, and chronic pulmonary disease</title><p id="Par26">We further carried out stratified analysis by sex, diabetes, obesity, and chronic pulmonary disease. Similar to the results observed in the general population, nicotine product use did not impact the risk of unfavorable discharge or prolonged LOS among any subgroup of patients (all, <italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05). Concerning complication rates, compared to non-users, men who used nicotine products had a significantly higher risk for any complications (aOR&#8201;=&#8201;1.45, 95% CI: 1.08&#8211;1.94, <italic toggle="yes">p</italic>&#8201;=&#8201;0.015) and infection (aOR&#8201;=&#8201;2.12, 95% CI: 1.22&#8211;3.70, <italic toggle="yes">p</italic>&#8201;=&#8201;0.008) after surgery, where this association was not observed in women.</p><p id="Par27">For the risk of any complication, nicotine product users had a significantly higher risk among individuals without diabetes (aOR&#8201;=&#8201;1.38, 95% CI: 1.10&#8211;1.74, <italic toggle="yes">p</italic>&#8201;=&#8201;0.006), without obesity (aOR&#8201;=&#8201;1.37, 95% CI: 1.08&#8211;1.73, <italic toggle="yes">p</italic>&#8201;=&#8201;0.009), and without chronic pulmonary disease (aOR&#8201;=&#8201;1.40, 95% CI: 1.09&#8211;1.79, <italic toggle="yes">p</italic>&#8201;=&#8201;0.007).</p><p id="Par28">For the risk of infection, nicotine product users had a significantly higher risk among individuals without diabetes (aOR&#8201;=&#8201;2.01, 95% CI: 1.23&#8211;3.28, <italic toggle="yes">p</italic>&#8201;=&#8201;0.005), without obesity (aOR&#8201;=&#8201;1.82, 95% CI: 1.14&#8211;2.90, <italic toggle="yes">p</italic>&#8201;=&#8201;0.012), and without chronic pulmonary disease (aOR&#8201;=&#8201;1.93, 95% CI: 1.20&#8211;3.10, <italic toggle="yes">p</italic>&#8201;=&#8201;0.007) (Table&#160;<xref rid="Tab4" ref-type="table">4</xref>).</p><p id="Par29">
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Stratified associations between smoking and outcomes by sex, comorbid hypertension, diabetes, obesity, and chronic pulmonary disease</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Subgroup</th><th align="left" rowspan="2" colspan="1">Nicotine product use</th><th align="left" colspan="2" rowspan="1">Unfavorable discharge <sup>a, e</sup></th><th align="left" colspan="2" rowspan="1">Prolonged LOS <sup>b, e, f</sup></th><th align="left" colspan="2" rowspan="1">Any complications <sup>c</sup></th><th align="left" colspan="2" rowspan="1">Infection <sup>d</sup></th></tr><tr><th align="left" colspan="1" rowspan="1">aOR (95% CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th><th align="left" colspan="1" rowspan="1">aOR (95% CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th><th align="left" colspan="1" rowspan="1">aOR (95% CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th><th align="left" colspan="1" rowspan="1">aOR (95% CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">
<bold>Sex</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Male</td><td align="left" colspan="1" rowspan="1">Yes vs. No</td><td align="left" colspan="1" rowspan="1">1.52 (0.88&#8211;2.64)</td><td align="left" colspan="1" rowspan="1">0.133</td><td align="left" colspan="1" rowspan="1">1.26 (0.96&#8211;1.65)</td><td align="left" colspan="1" rowspan="1">0.100</td><td align="left" colspan="1" rowspan="1">1.45 (1.08&#8211;1.94)</td><td align="left" colspan="1" rowspan="1">
<bold>0.015</bold>
</td><td align="left" colspan="1" rowspan="1">2.12 (1.22&#8211;3.70)</td><td align="left" colspan="1" rowspan="1">
<bold>0.008</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Female</td><td align="left" colspan="1" rowspan="1">Yes vs. No</td><td align="left" colspan="1" rowspan="1">0.98 (0.53&#8211;1.80)</td><td align="left" colspan="1" rowspan="1">0.945</td><td align="left" colspan="1" rowspan="1">0.93 (0.72&#8211;1.21)</td><td align="left" colspan="1" rowspan="1">0.589</td><td align="left" colspan="1" rowspan="1">1.26 (0.93&#8211;1.70)</td><td align="left" colspan="1" rowspan="1">0.137</td><td align="left" colspan="1" rowspan="1">1.35 (0.73&#8211;2.52)</td><td align="left" colspan="1" rowspan="1">0.344</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Diabetes</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">Yes vs. No</td><td align="left" colspan="1" rowspan="1">1.23 (0.77&#8211;1.96)</td><td align="left" colspan="1" rowspan="1">0.383</td><td align="left" colspan="1" rowspan="1">1.06 (0.87&#8211;1.30)</td><td align="left" colspan="1" rowspan="1">0.565</td><td align="left" colspan="1" rowspan="1">1.38 (1.10&#8211;1.74)</td><td align="left" colspan="1" rowspan="1">
<bold>0.006</bold>
</td><td align="left" colspan="1" rowspan="1">2.01 (1.23&#8211;3.28)</td><td align="left" colspan="1" rowspan="1">
<bold>0.005</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">Yes vs. No</td><td align="left" colspan="1" rowspan="1">1.84 (0.72&#8211;4.68)</td><td align="left" colspan="1" rowspan="1">0.201</td><td align="left" colspan="1" rowspan="1">1.23 (0.75&#8211;2.03)</td><td align="left" colspan="1" rowspan="1">0.412</td><td align="left" colspan="1" rowspan="1">1.36 (0.82&#8211;2.26)</td><td align="left" colspan="1" rowspan="1">0.238</td><td align="left" colspan="1" rowspan="1">1.09 (0.45&#8211;2.63)</td><td align="left" colspan="1" rowspan="1">0.843</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Obesity</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">Yes vs. No</td><td align="left" colspan="1" rowspan="1">1.27 (0.81&#8211;1.99)</td><td align="left" colspan="1" rowspan="1">0.296</td><td align="left" colspan="1" rowspan="1">1.14 (0.93&#8211;1.41)</td><td align="left" colspan="1" rowspan="1">0.202</td><td align="left" colspan="1" rowspan="1">1.37 (1.08&#8211;1.73)</td><td align="left" colspan="1" rowspan="1">
<bold>0.009</bold>
</td><td align="left" colspan="1" rowspan="1">1.82 (1.14&#8211;2.90)</td><td align="left" colspan="1" rowspan="1">
<bold>0.012</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">Yes vs. No</td><td align="left" colspan="1" rowspan="1">1.21 (0.42&#8211;3.51)</td><td align="left" colspan="1" rowspan="1">0.725</td><td align="left" colspan="1" rowspan="1">0.80 (0.49&#8211;1.30)</td><td align="left" colspan="1" rowspan="1">0.362</td><td align="left" colspan="1" rowspan="1">1.44 (0.88&#8211;2.36)</td><td align="left" colspan="1" rowspan="1">0.148</td><td align="left" colspan="1" rowspan="1">1.44 (0.56&#8211;3.72)</td><td align="left" colspan="1" rowspan="1">0.455</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Chronic pulmonary disease</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">Yes vs. No</td><td align="left" colspan="1" rowspan="1">1.43 (0.90&#8211;2.29)</td><td align="left" colspan="1" rowspan="1">0.130</td><td align="left" colspan="1" rowspan="1">1.10 (0.89&#8211;1.36)</td><td align="left" colspan="1" rowspan="1">0.361</td><td align="left" colspan="1" rowspan="1">1.40 (1.09&#8211;1.79)</td><td align="left" colspan="1" rowspan="1">
<bold>0.007</bold>
</td><td align="left" colspan="1" rowspan="1">1.93 (1.20&#8211;3.10)</td><td align="left" colspan="1" rowspan="1">
<bold>0.007</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">Yes vs. No</td><td align="left" colspan="1" rowspan="1">0.85 (0.35&#8211;2.06)</td><td align="left" colspan="1" rowspan="1">0.719</td><td align="left" colspan="1" rowspan="1">0.98 (0.65&#8211;1.49)</td><td align="left" colspan="1" rowspan="1">0.929</td><td align="left" colspan="1" rowspan="1">1.27 (0.84&#8211;1.92)</td><td align="left" colspan="1" rowspan="1">0.265</td><td align="left" colspan="1" rowspan="1">1.33 (0.56&#8211;3.16)</td><td align="left" colspan="1" rowspan="1">0.524</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: LOS, length of hospital stay; aOR, adjusted odds ratio; CI, confidence interval; CCI, Charlson comorbidity index</p><p>p-values&#8201;&lt;&#8201;0.05 are shown in bold</p><p><sup>a</sup> Adjusted for variables that were significant (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) in the univariate analysis (except for CCI and stratified variables), including age (continuous), race, insurance status / primary payer, admission type, admission type, receiving cervical spine fusion, ischemic heart disease, atrial fibrillation, hypertension, diabetes, chronic pulmonary disease, chronic kidney disease, rheumatic disease, any malignancy, hospital bed size, and location / teaching status</p><p><sup>b</sup> Adjusted for significant variables (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) in the univariate analysis (except for CCI and stratified variables), including age (continuous), race, income, insurance status / primary payer, admission type, receiving cervical spine fusion, ischemic heart disease, atrial fibrillation, hypertension, diabetes, obesity, chronic pulmonary disease, chronic kidney disease, any malignancy, hospital bed size, and location / teaching status</p><p><sup>c</sup> Adjusted for significant variables (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) in the univariate analysis (except for CCI and stratified variables), including age (continuous), race, insurance status / primary payer, admission type, receiving cervical spine fusion, ischemic heart disease, atrial fibrillation, hypertension, diabetes, obesity, chronic pulmonary disease, chronic kidney disease, rheumatic disease, any malignancy, and location / teaching status</p><p><sup>d</sup> Adjusted for variables that were significant (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) in the univariate analysis (except for CCI and stratified variables), including age (continuous), income, insurance status / primary payer, admission type, hypertension, diabetes, chronic pulmonary disease, chronic kidney disease, rheumatic disease, any malignancy, and location / teaching status</p><p><sup>e</sup> Excluding patients who died in the hospital</p><p><sup>f</sup> LOS&#8201;&gt;&#8201;75th percentile: 2 days</p></table-wrap-foot></table-wrap>
</p></sec></sec><sec id="Sec13"><title>Discussion</title><p id="Par30">This study investigated the impact of nicotine product use on the outcomes of US adults undergoing CDA. After PSM, nicotine product users exhibited significantly higher rates of complications post-surgery. In multivariable analysis, nicotine product users had a higher risk of having any complications, and a 74% higher risk of infection, compared to non-users. However, no significant correlation was observed between nicotine product use and the likelihood of unfavorable discharge or prolonged LOS. In the stratified analyses, consistent trends were noted. Male nicotine product users had a greater risk of having any complications, and twice the risk of infection post-surgery. However, this association was not present in female nicotine product users. Additionally, individuals without diabetes, obesity, and chronic pulmonary disease who used nicotine products had significantly higher risks of complications and infection compared to non-users.</p><p id="Par31">Smoking is associated with worse outcomes of surgical procedures [<xref ref-type="bibr" rid="CR18">18</xref>]. Our results align with previous studies that document the adverse effects of smoking on spinal surgery outcomes. For instance, Purvis et al. found that smoking status was significantly associated with increased complications in ACDF [<xref ref-type="bibr" rid="CR19">19</xref>]&#8203;. Similarly, Wen-Shen et al. [<xref ref-type="bibr" rid="CR20">20</xref>] reported that smokers and non-smokers undergoing cervical artificial disc replacement had similar functional outcomes, but smokers had a significantly higher risk of requiring revision surgery 2 years after the initial procedure. A review of the literature by V Khurana concluded that smoking accelerates spondylosis and can lead to early surgery, delayed wound healing, increased rates of surgical site infections, failed fusion, re-operations, and chronic spine pain [<xref ref-type="bibr" rid="CR21">21</xref>]. These studies collectively highlight the detrimental impact of smoking on surgical recovery, reinforcing the need for smoking cessation interventions in surgical patients. Contrastingly, Tu et al. observed no significant differences in clinical outcomes between smokers and non-smokers undergoing CDA, suggesting that smoking did not negatively impact postoperative recovery [<xref ref-type="bibr" rid="CR13">13</xref>]&#8203;&#8203;. However, their study was limited by a small sample size of smokers, potentially underestimating the true impact of smoking. Our study, utilizing a larger dataset, provides more robust evidence of the risks associated with nicotine product use in CDA patients, particularly in infection rates.</p><p id="Par32">Our stratified analysis showed that nicotine product use is associated with an elevated infection risk in males but not females. Differences in nicotine product usage patterns between males and females, such as the frequency and intensity of use, may contribute to this discrepancy. If males, on average, use nicotine products more frequently or in higher doses than females, they could be at higher risk for nicotine-related complications, including infections [<xref ref-type="bibr" rid="CR22">22</xref>]. Unfortunately, we did not have access to detailed information on nicotine product consumption, such as pack-years for cigarette smoking or equivalent metrics for other nicotine products, and thus could not perform further analysis.</p><p id="Par33">Our stratified analysis further revealed that the correlation between nicotine product use and infection risk was evident solely among individuals who did not have diabetes, obesity, or chronic pulmonary disease. This could be explained by the fact that these comorbidities may have a greater impact on post-surgical complications, potentially masking the effects of nicotine product use. While there is no literature regarding the impact of such comorbidities on CDA outcomes, some studies have examined their impacts on the outcomes of ACDF. For example, Malik et al. [<xref ref-type="bibr" rid="CR23">23</xref>] reported that metabolic syndrome was significantly associated with a prolonged length of stay&#8201;&#8805;&#8201;3 days (OR&#8201;=&#8201;1.32) in patients undergoing ACDF, but was not associated with 30-day complications, reoperations, or re-admissions, non-home discharge, or death. Interestingly, Sielatycki et al. [<xref ref-type="bibr" rid="CR24">24</xref>] reported that obesity did not influence the outcomes of patients undergoing elective ACDF.</p><p id="Par34">There are multiple mechanisms through which nicotine product use may increase the risk of infections in patients undergoing surgery. Nicotine impairs the immune system, reducing its efficiency in combating infections [<xref ref-type="bibr" rid="CR25">25</xref>]. Furthermore, it leads to the constriction of blood vessels and diminished blood flow to the surgical site which compromises the healing process due to reduced delivery of essential nutrients and immune cells to the area [<xref ref-type="bibr" rid="CR25">25</xref>]. Notably, Liu et al. [<xref ref-type="bibr" rid="CR26">26</xref>] compared postoperative wound healing between smokers, non-smokers, and persons who had stopped smoking. The results showed that wound healing problems and surgical site infections were significantly lower in non-smokers and persons who had stopped smoking than in active smokers. Our observation is generally consistent with these prior reports.</p><p id="Par35">While our investigation identified nicotine product use as an adverse predictor of infections in patients undergoing CDA, we were unable to analyze the impact of preoperative nicotine cessation due to a lack of such data. Prior literature in the realm of spinal surgeries emphasizes nicotine cessation as a promising strategy for potentially mitigating various short-term adverse events [<xref ref-type="bibr" rid="CR27">27</xref>&#8211;<xref ref-type="bibr" rid="CR29">29</xref>]. However, a recent study shed light on a contrasting finding: patients undergoing smoking cessation therapy before single-level anterior cervical discectomy and fusion procedures exhibited heightened vulnerability to postoperative dysphagia and revision surgery compared to their smoking counterparts [<xref ref-type="bibr" rid="CR30">30</xref>]. Despite mixed findings, our study suggests that clinicians should prioritize nicotine cessation for CDA patients, recommending a 4&#8211;6-week cessation period pre-surgery to reduce risks. Tailored postoperative care, including vigilant infection monitoring, is also crucial. Further research is needed to clarify the long-term benefits and specific impacts of nicotine cessation on CDA outcomes.</p><sec id="Sec14"><title>Strengths and limitations</title><p id="Par36">This study leveraged the NIS database from 2005 to 2020, offering a vast and diverse patient base that enhances the applicability of its findings on the impact of nicotine product use on CDA outcomes across the US. By employing PSM, it adjusts for potential confounding factors as much as possible, providing a more balanced comparison of post-surgical complications, infections, and other outcomes. The inclusion of stratified analyses for various subgroups allows for more personalized insights into patient care. However, the retrospective nature of the study limits its ability to consider all potential confounding factors, and the reliance on ICD-coded conditions and procedures may introduce biases if any coding errors exist. While PSM reduces selection bias, it cannot fully eliminate confounders like disease severity, such as HbA1c differences in diabetic patients. Additionally, the database lacks granular clinical details, such as laboratory values and functional status, which may affect risk adjustment and outcome interpretation. In addition, the dataset does not include information on specific medication types for diabetic patients, limiting the ability to perform a subanalysis comparing first-line versus second-line treatments. A limitation is the inability to differentiate between deep and superficial infections. Additionally, the dataset lacks clinical information, such as the actual severity of the disease and surgical invasiveness (e.g., blood loss and operation time), and long-term outcomes. Complications were only captured during the hospitalization, and data on post-discharge events or follow-up are unavailable. Changes in surgical techniques over the study period could also influence results. Notably, the identification of nicotine product use through ICD codes fails to capture the intensity and duration of use, such as pack-years for cigarette smoking or equivalent measures for other nicotine products, which limits the understanding of nicotine product use&#8217;s true impact on CDA outcomes. Finally, the absence of data on preoperative nicotine cessation efforts limits the ability to evaluate its potential benefits.</p><p id="Par37">Despite these limitations, the study&#8217;s comprehensive approach contributes to the literature and highlights the need for further research, including datasets with more granular clinical details and long-term follow-up, to better understand the implications of nicotine product use on CDA outcomes.</p></sec></sec><sec id="Sec15"><title>Conclusions</title><p id="Par38">This population-based study demonstrates that nicotine product use significantly increases the risk of complications, particularly infections, following CDA, particularly among male nicotine product users and patients without coexisting conditions like diabetes, obesity, or chronic pulmonary disease. While nicotine product use did not influence the rates of unfavorable discharge or extended hospital stay, its impact on post-surgical outcomes still underscores the need for targeted interventions and risk stratification in surgical planning for nicotine product users.</p></sec><sec id="Sec16" sec-type="supplementary-material"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="13018_2025_5700_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>None.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Conceptualization: Yu-Jun Lin. Data curation: Yu-Jun Lin, Fu-Yuan Shih. Formal Analysis: Jin-Fu Huang. Funding acquisition: Yu-Jun Lin. Investigation: Chun-Wei Ting. Methodology: Yu-Jun Lin, Fu-Yuan Shih, Jin-Fu Huang. Project administration: Yu-Chin Tsai, Lin Chang. Resources: Yu-Jun Lin. Software: Jin-Fu Huang, Chun-Wei Ting. Supervision: Hung-Cheng Wang, Wu-Fu Chen. Validation: Yu-Jun Lin, Lin Chang. Visualization: Yu-Chin Tsai, Lin Chang. Writing &#8211; original draft: Yu-Jun Lin, Fu-Yun Shih, Jin-Fu Huang, Chun-Wei, Ting. Writing &#8211; review &amp; editing: Hung-Cheng Wang, Wu-Fu Chen. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>None.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar2"><title>Ethics approval and consent to participate</title><p id="Par39">This was a population-based, retrospective study. This study complies with the terms of the NIS data-use agreement. The data utilized in this study were obtained through the Online HCUP Central Distributor. Given that this study solely involved the analysis of secondary data, there was no direct involvement of the general public or patients.</p></notes><notes id="FPar3"><title>Consent for publication</title><p id="Par40">Not applicable.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests</title><p id="Par41">The authors declare no competing interests.</p></notes></notes><glossary><title>Abbreviations</title><def-list><def-item><term>CDA</term><def><p id="Par42">Cervical disc arthroplasty</p></def></def-item><def-item><term>PSM</term><def><p id="Par43">Propensity score matching</p></def></def-item><def-item><term>LOS</term><def><p id="Par44">length of stay</p></def></def-item><def-item><term>COPD</term><def><p id="Par45">Chronic obstructive pulmonary disease</p></def></def-item><def-item><term>AMI</term><def><p id="Par46">Acute myocardial infarction</p></def></def-item><def-item><term>VTE</term><def><p id="Par47">Venous thromboembolism</p></def></def-item><def-item><term>CVA</term><def><p id="Par48">Cerebrovascular accident</p></def></def-item><def-item><term>AKI</term><def><p id="Par49">Acute kidney injury</p></def></def-item><def-item><term>CCI</term><def><p id="Par50">Charlson Comorbidity Index</p></def></def-item></def-list></glossary><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saunders</surname><given-names>LM</given-names></name><name name-style="western"><surname>Sandhu</surname><given-names>HS</given-names></name><name name-style="western"><surname>McBride</surname><given-names>L</given-names></name><name name-style="western"><surname>Maniarasu</surname><given-names>VS</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>S</given-names></name><name name-style="western"><surname>Dhokia</surname><given-names>R</given-names></name></person-group><article-title>Degenerative cervical myelopathy: an overview</article-title><source>Cureus</source><year>2023</year><volume>15</volume><issue>12</issue><fpage>e50387</fpage><pub-id pub-id-type="pmid">38213348</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.50387</pub-id><pub-id pub-id-type="pmcid">PMC10783125</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Saunders LM, Sandhu HS, McBride L, Maniarasu VS, Taylor S, Dhokia R. Degenerative cervical myelopathy: an overview. Cureus. 2023;15(12):e50387.<pub-id pub-id-type="pmid">38213348</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.50387</pub-id><pub-id pub-id-type="pmcid">PMC10783125</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baucher</surname><given-names>G</given-names></name><name name-style="western"><surname>Taskovic</surname><given-names>J</given-names></name><name name-style="western"><surname>Troude</surname><given-names>L</given-names></name><name name-style="western"><surname>Molliqaj</surname><given-names>G</given-names></name><name name-style="western"><surname>Nouri</surname><given-names>A</given-names></name><name name-style="western"><surname>Tessitore</surname><given-names>E</given-names></name></person-group><article-title>Risk factors for the development of degenerative cervical myelopathy: a review of the literature</article-title><source>Neurosurg Rev</source><year>2022</year><volume>45</volume><issue>2</issue><fpage>1675</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1007/s10143-021-01698-9</pub-id><pub-id pub-id-type="pmid">34845577</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Baucher G, Taskovic J, Troude L, Molliqaj G, Nouri A, Tessitore E. Risk factors for the development of degenerative cervical myelopathy: a review of the literature. Neurosurg Rev. 2022;45(2):1675&#8211;89.<pub-id pub-id-type="pmid">34845577</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10143-021-01698-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>XR</given-names></name><name name-style="western"><surname>Kwok</surname><given-names>TCY</given-names></name><name name-style="western"><surname>Griffith</surname><given-names>JF</given-names></name><name name-style="western"><surname>Man Yu</surname><given-names>BW</given-names></name><name name-style="western"><surname>Leung</surname><given-names>JCS</given-names></name><name name-style="western"><surname>W&#225;ng</surname><given-names>YXJ</given-names></name></person-group><article-title>Prevalence of cervical spine degenerative changes in elderly population and its weak association with aging, neck pain, and osteoporosis</article-title><source>Ann Transl Med</source><year>2019</year><volume>7</volume><issue>18</issue><fpage>486</fpage><pub-id pub-id-type="doi">10.21037/atm.2019.07.80</pub-id><pub-id pub-id-type="pmid">31700922</pub-id><pub-id pub-id-type="pmcid">PMC6803181</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Wang XR, Kwok TCY, Griffith JF, Man Yu BW, Leung JCS, W&#225;ng YXJ. Prevalence of cervical spine degenerative changes in elderly population and its weak association with aging, neck pain, and osteoporosis. Ann Transl Med. 2019;7(18):486.<pub-id pub-id-type="pmid">31700922</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/atm.2019.07.80</pub-id><pub-id pub-id-type="pmcid">PMC6803181</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>J</given-names></name><name name-style="western"><surname>D&#8217;Amore</surname><given-names>P</given-names></name><name name-style="western"><surname>Redlich</surname><given-names>N</given-names></name><name name-style="western"><surname>Darlow</surname><given-names>M</given-names></name><name name-style="western"><surname>Suwak</surname><given-names>P</given-names></name><name name-style="western"><surname>Sarkovich</surname><given-names>S</given-names></name><etal/></person-group><article-title>Degenerative cervical myelopathy: evaluation and management</article-title><source>Orthop Clin North Am</source><year>2022</year><volume>53</volume><issue>4</issue><fpage>509</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.ocl.2022.05.007</pub-id><pub-id pub-id-type="pmid">36208893</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Williams J, D&#8217;Amore P, Redlich N, Darlow M, Suwak P, Sarkovich S, et al. Degenerative cervical myelopathy: evaluation and management. Orthop Clin North Am. 2022;53(4):509&#8211;21.<pub-id pub-id-type="pmid">36208893</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ocl.2022.05.007</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laratta</surname><given-names>JL</given-names></name><name name-style="western"><surname>Shillingford</surname><given-names>JN</given-names></name><name name-style="western"><surname>Saifi</surname><given-names>C</given-names></name><name name-style="western"><surname>Riew</surname><given-names>KD</given-names></name></person-group><article-title>Cervical disc arthroplasty: A comprehensive review of Single-Level, multilevel, and hybrid procedures</article-title><source>Global Spine J</source><year>2018</year><volume>8</volume><issue>1</issue><fpage>78</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1177/2192568217701095</pub-id><pub-id pub-id-type="pmid">29456918</pub-id><pub-id pub-id-type="pmcid">PMC5810892</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Laratta JL, Shillingford JN, Saifi C, Riew KD. Cervical disc arthroplasty: A comprehensive review of Single-Level, multilevel, and hybrid procedures. Global Spine J. 2018;8(1):78&#8211;83.<pub-id pub-id-type="pmid">29456918</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/2192568217701095</pub-id><pub-id pub-id-type="pmcid">PMC5810892</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>AQ</given-names></name><name name-style="western"><surname>Credille</surname><given-names>K</given-names></name><name name-style="western"><surname>Saifi</surname><given-names>C</given-names></name></person-group><article-title>Short-term and Long-term complications of cervical disc arthroplasty</article-title><source>Clin Spine Surg</source><year>2023</year><volume>36</volume><issue>9</issue><fpage>404</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">37752635</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/BSD.0000000000001541</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Nguyen AQ, Credille K, Saifi C. Short-term and Long-term complications of cervical disc arthroplasty. Clin Spine Surg. 2023;36(9):404&#8211;10.<pub-id pub-id-type="pmid">37752635</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/BSD.0000000000001541</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Nilssen PK, Narendran N, Chen I, Kanim LE, Walker CT, Bae HW et al. Risk factors for reoperation following Single-Level cervical disc arthroplasty as utilized in a representative sample of united States clinical practice: A retrospective pearldiver study. Global Spine J. 2024:21925682241230965.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/21925682241230965</pub-id><pub-id pub-id-type="pmcid">PMC11572117</pub-id><pub-id pub-id-type="pmid">38279691</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>K</given-names></name><name name-style="western"><surname>Tartarone</surname><given-names>A</given-names></name><name name-style="western"><surname>P&#233;rez-R&#237;os</surname><given-names>M</given-names></name><name name-style="western"><surname>Novello</surname><given-names>S</given-names></name><name name-style="western"><surname>Mariniello</surname><given-names>A</given-names></name><name name-style="western"><surname>Roviello</surname><given-names>G</given-names></name><etal/></person-group><article-title>Smoking burden, MPOWER, future tobacco control and real-world challenges in China: reflections on the WHO report on the global tobacco epidemic 2021</article-title><source>Transl Lung Cancer Res</source><year>2022</year><volume>11</volume><issue>1</issue><fpage>117</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.21037/tlcr-22-27</pub-id><pub-id pub-id-type="pmid">35242633</pub-id><pub-id pub-id-type="pmcid">PMC8825659</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Zhang K, Tartarone A, P&#233;rez-R&#237;os M, Novello S, Mariniello A, Roviello G, et al. Smoking burden, MPOWER, future tobacco control and real-world challenges in China: reflections on the WHO report on the global tobacco epidemic 2021. Transl Lung Cancer Res. 2022;11(1):117&#8211;21.<pub-id pub-id-type="pmid">35242633</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/tlcr-22-27</pub-id><pub-id pub-id-type="pmcid">PMC8825659</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gallucci</surname><given-names>G</given-names></name><name name-style="western"><surname>Tartarone</surname><given-names>A</given-names></name><name name-style="western"><surname>Lerose</surname><given-names>R</given-names></name><name name-style="western"><surname>Lalinga</surname><given-names>AV</given-names></name><name name-style="western"><surname>Capobianco</surname><given-names>AM</given-names></name></person-group><article-title>Cardiovascular risk of smoking and benefits of smoking cessation</article-title><source>J Thorac Dis</source><year>2020</year><volume>12</volume><issue>7</issue><fpage>3866</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.21037/jtd.2020.02.47</pub-id><pub-id pub-id-type="pmid">32802468</pub-id><pub-id pub-id-type="pmcid">PMC7399440</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Gallucci G, Tartarone A, Lerose R, Lalinga AV, Capobianco AM. Cardiovascular risk of smoking and benefits of smoking cessation. J Thorac Dis. 2020;12(7):3866&#8211;76.<pub-id pub-id-type="pmid">32802468</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/jtd.2020.02.47</pub-id><pub-id pub-id-type="pmcid">PMC7399440</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gan</surname><given-names>H</given-names></name><name name-style="western"><surname>Hou</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xue</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Smoking: a leading factor for the death of chronic respiratory diseases derived from global burden of disease study 2019</article-title><source>BMC Pulm Med</source><year>2022</year><volume>22</volume><issue>1</issue><fpage>149</fpage><pub-id pub-id-type="doi">10.1186/s12890-022-01944-w</pub-id><pub-id pub-id-type="pmid">35443660</pub-id><pub-id pub-id-type="pmcid">PMC9019969</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Gan H, Hou X, Zhu Z, Xue M, Zhang T, Huang Z, et al. Smoking: a leading factor for the death of chronic respiratory diseases derived from global burden of disease study 2019. BMC Pulm Med. 2022;22(1):149.<pub-id pub-id-type="pmid">35443660</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12890-022-01944-w</pub-id><pub-id pub-id-type="pmcid">PMC9019969</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>SC</given-names></name><name name-style="western"><surname>Son</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>DW</given-names></name><name name-style="western"><surname>Han</surname><given-names>CH</given-names></name><name name-style="western"><surname>Choi</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SW</given-names></name><etal/></person-group><article-title>Smoking and the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection</article-title><source>Nicotine Tob Res</source><year>2021</year><volume>23</volume><issue>10</issue><fpage>1787</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1093/ntr/ntab079</pub-id><pub-id pub-id-type="pmid">33891697</pub-id><pub-id pub-id-type="pmcid">PMC8135532</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Lee SC, Son KJ, Kim DW, Han CH, Choi YJ, Kim SW, et al. Smoking and the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nicotine Tob Res. 2021;23(10):1787&#8211;92.<pub-id pub-id-type="pmid">33891697</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ntr/ntab079</pub-id><pub-id pub-id-type="pmcid">PMC8135532</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Meng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Hong</surname><given-names>Y</given-names></name></person-group><article-title>The impact of smoking on outcomes following anterior cervical fusion-nonfusion hybrid surgery: a retrospective single-center cohort study</article-title><source>BMC Musculoskelet Disord</source><year>2021</year><volume>22</volume><issue>1</issue><fpage>612</fpage><pub-id pub-id-type="doi">10.1186/s12891-021-04501-4</pub-id><pub-id pub-id-type="pmid">34243728</pub-id><pub-id pub-id-type="pmcid">PMC8272305</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Wang H, Meng Y, Liu H, Wang X, Hong Y. The impact of smoking on outcomes following anterior cervical fusion-nonfusion hybrid surgery: a retrospective single-center cohort study. BMC Musculoskelet Disord. 2021;22(1):612.<pub-id pub-id-type="pmid">34243728</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12891-021-04501-4</pub-id><pub-id pub-id-type="pmcid">PMC8272305</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tu</surname><given-names>TH</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>CH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>WC</given-names></name><name name-style="western"><surname>Fay</surname><given-names>LY</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>H</given-names></name><name name-style="western"><surname>Wu</surname><given-names>JC</given-names></name></person-group><article-title>Effects of smoking on cervical disc arthroplasty</article-title><source>J Neurosurg Spine</source><year>2019</year><volume>30</volume><issue>2</issue><fpage>168</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.3171/2018.7.SPINE18634</pub-id><pub-id pub-id-type="pmid">31066538</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Tu TH, Kuo CH, Huang WC, Fay LY, Cheng H, Wu JC. Effects of smoking on cervical disc arthroplasty. J Neurosurg Spine. 2019;30(2):168&#8211;74.<pub-id pub-id-type="pmid">31066538</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3171/2018.7.SPINE18634</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">Lawand J, Ghali A, Hauck J, Trejo Corona S, Gonzalez R, Deveza L. The smokeless paradox: Nontobacco nicotine use and complications in anterior cervical discectomy and fusion. J Am Acad Orthop Surg. 2024.<pub-id pub-id-type="doi" assigning-authority="pmc">10.5435/JAAOS-D-24-00801</pub-id><pub-id pub-id-type="pmid">39705814</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>K</given-names></name><name name-style="western"><surname>Furuta</surname><given-names>K</given-names></name><name name-style="western"><surname>Adachi</surname><given-names>K</given-names></name><name name-style="western"><surname>Ohara</surname><given-names>S</given-names></name><name name-style="western"><surname>Morita</surname><given-names>T</given-names></name><name name-style="western"><surname>Tanimura</surname><given-names>T</given-names></name><etal/></person-group><article-title>Effects of anti-hypertensive drugs on esophageal body contraction</article-title><source>World J Gastroenterol</source><year>2010</year><volume>16</volume><issue>8</issue><fpage>987</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.3748/wjg.v16.i8.987</pub-id><pub-id pub-id-type="pmid">20180238</pub-id><pub-id pub-id-type="pmcid">PMC2828604</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Yoshida K, Furuta K, Adachi K, Ohara S, Morita T, Tanimura T, et al. Effects of anti-hypertensive drugs on esophageal body contraction. World J Gastroenterol. 2010;16(8):987&#8211;91.<pub-id pub-id-type="pmid">20180238</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3748/wjg.v16.i8.987</pub-id><pub-id pub-id-type="pmcid">PMC2828604</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charlson</surname><given-names>ME</given-names></name><name name-style="western"><surname>Carrozzino</surname><given-names>D</given-names></name><name name-style="western"><surname>Guidi</surname><given-names>J</given-names></name><name name-style="western"><surname>Patierno</surname><given-names>C</given-names></name></person-group><article-title>Charlson comorbidity index: A critical review of clinimetric properties</article-title><source>Psychother Psychosom</source><year>2022</year><volume>91</volume><issue>1</issue><fpage>8</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1159/000521288</pub-id><pub-id pub-id-type="pmid">34991091</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson comorbidity index: A critical review of clinimetric properties. Psychother Psychosom. 2022;91(1):8&#8211;35.<pub-id pub-id-type="pmid">34991091</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000521288</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Parsons LS, editor. Performing a 1: N case-control match on propensity score. Proceedings of the 29th Annual SAS users group international conference; 2004: SAS Institute Montreal, Canada.</mixed-citation></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshikawa</surname><given-names>R</given-names></name><name name-style="western"><surname>Katada</surname><given-names>J</given-names></name></person-group><article-title>Effects of active smoking on postoperative outcomes in hospitalised patients undergoing elective surgery: a retrospective analysis of an administrative claims database in Japan</article-title><source>BMJ Open</source><year>2019</year><volume>9</volume><issue>10</issue><fpage>e029913</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2019-029913</pub-id><pub-id pub-id-type="pmid">31575535</pub-id><pub-id pub-id-type="pmcid">PMC6797353</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Yoshikawa R, Katada J. Effects of active smoking on postoperative outcomes in hospitalised patients undergoing elective surgery: a retrospective analysis of an administrative claims database in Japan. BMJ Open. 2019;9(10):e029913.<pub-id pub-id-type="pmid">31575535</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2019-029913</pub-id><pub-id pub-id-type="pmcid">PMC6797353</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Purvis</surname><given-names>TE</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>AK</given-names></name><name name-style="western"><surname>Boone</surname><given-names>C</given-names></name><name name-style="western"><surname>De la Garza-Ramos</surname><given-names>R</given-names></name><name name-style="western"><surname>Elder</surname><given-names>BD</given-names></name><etal/></person-group><article-title>Impact of smoking on postoperative complications after anterior cervical discectomy and fusion</article-title><source>J Clin Neurosci</source><year>2017</year><volume>38</volume><fpage>106</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.jocn.2016.12.044</pub-id><pub-id pub-id-type="pmid">28110928</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Purvis TE, Rodriguez HJ, Ahmed AK, Boone C, De la Garza-Ramos R, Elder BD, et al. Impact of smoking on postoperative complications after anterior cervical discectomy and fusion. J Clin Neurosci. 2017;38:106&#8211;10.<pub-id pub-id-type="pmid">28110928</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jocn.2016.12.044</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wen-Shen</surname><given-names>L</given-names></name><name name-style="western"><surname>Sheng</surname><given-names>MLW</given-names></name><name name-style="western"><surname>Yeo</surname><given-names>W</given-names></name><name name-style="western"><surname>Beng</surname><given-names>TS</given-names></name><name name-style="western"><surname>Mun</surname><given-names>YW</given-names></name><name name-style="western"><surname>Ming</surname><given-names>GC</given-names></name><etal/></person-group><article-title>No difference in functional outcome but higher revision rate among smokers undergoing cervical artificial disc replacement: analysis of a spine registry</article-title><source>Int J Spine Surg</source><year>2020</year><volume>14</volume><issue>6</issue><fpage>916</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.14444/7140</pub-id><pub-id pub-id-type="pmid">33560251</pub-id><pub-id pub-id-type="pmcid">PMC7872401</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Wen-Shen L, Sheng MLW, Yeo W, Beng TS, Mun YW, Ming GC, et al. No difference in functional outcome but higher revision rate among smokers undergoing cervical artificial disc replacement: analysis of a spine registry. Int J Spine Surg. 2020;14(6):916&#8211;23.<pub-id pub-id-type="pmid">33560251</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.14444/7140</pub-id><pub-id pub-id-type="pmcid">PMC7872401</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khurana</surname><given-names>VG</given-names></name></person-group><article-title>Adverse impact of smoking on the spine and spinal surgery</article-title><source>Surg Neurol Int</source><year>2021</year><volume>12</volume><fpage>118</fpage><pub-id pub-id-type="doi">10.25259/SNI_6_2021</pub-id><pub-id pub-id-type="pmid">33880223</pub-id><pub-id pub-id-type="pmcid">PMC8053459</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Khurana VG. Adverse impact of smoking on the spine and spinal surgery. Surg Neurol Int. 2021;12:118.<pub-id pub-id-type="pmid">33880223</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.25259/SNI_6_2021</pub-id><pub-id pub-id-type="pmcid">PMC8053459</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashare</surname><given-names>RL</given-names></name><name name-style="western"><surname>Wetherill</surname><given-names>RR</given-names></name></person-group><article-title>The intersection of sex differences, tobacco use, and inflammation: implications for psychiatric disorders</article-title><source>Curr Psychiatry Rep</source><year>2018</year><volume>20</volume><issue>9</issue><fpage>75</fpage><pub-id pub-id-type="doi">10.1007/s11920-018-0946-3</pub-id><pub-id pub-id-type="pmid">30094593</pub-id><pub-id pub-id-type="pmcid">PMC7018440</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Ashare RL, Wetherill RR. The intersection of sex differences, tobacco use, and inflammation: implications for psychiatric disorders. Curr Psychiatry Rep. 2018;20(9):75.<pub-id pub-id-type="pmid">30094593</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11920-018-0946-3</pub-id><pub-id pub-id-type="pmcid">PMC7018440</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malik</surname><given-names>AT</given-names></name><name name-style="western"><surname>Jain</surname><given-names>N</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name><name name-style="western"><surname>Yu</surname><given-names>E</given-names></name><name name-style="western"><surname>Khan</surname><given-names>SN</given-names></name></person-group><article-title>The impact of metabolic syndrome on 30-Day outcomes following elective anterior cervical discectomy and fusions</article-title><source>Spine (Phila Pa 1976)</source><year>2019</year><volume>44</volume><issue>5</issue><fpage>E282</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1097/BRS.0000000000002824</pub-id><pub-id pub-id-type="pmid">30074973</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Malik AT, Jain N, Kim J, Yu E, Khan SN. The impact of metabolic syndrome on 30-Day outcomes following elective anterior cervical discectomy and fusions. Spine (Phila Pa 1976). 2019;44(5):E282&#8211;7.<pub-id pub-id-type="pmid">30074973</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/BRS.0000000000002824</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sielatycki</surname><given-names>JA</given-names></name><name name-style="western"><surname>Chotai</surname><given-names>S</given-names></name><name name-style="western"><surname>Kay</surname><given-names>H</given-names></name><name name-style="western"><surname>Stonko</surname><given-names>D</given-names></name><name name-style="western"><surname>McGirt</surname><given-names>M</given-names></name><name name-style="western"><surname>Devin</surname><given-names>CJ</given-names></name></person-group><article-title>Does obesity correlate with worse Patient-Reported outcomes following elective anterior cervical discectomy and fusion??</article-title><source>Neurosurgery</source><year>2016</year><volume>79</volume><issue>1</issue><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1227/NEU.0000000000001252</pub-id><pub-id pub-id-type="pmid">27166659</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Sielatycki JA, Chotai S, Kay H, Stonko D, McGirt M, Devin CJ. Does obesity correlate with worse Patient-Reported outcomes following elective anterior cervical discectomy and fusion?? Neurosurgery. 2016;79(1):69&#8211;74.<pub-id pub-id-type="pmid">27166659</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1227/NEU.0000000000001252</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saint-Andr&#233;</surname><given-names>V</given-names></name><name name-style="western"><surname>Charbit</surname><given-names>B</given-names></name><name name-style="western"><surname>Biton</surname><given-names>A</given-names></name><name name-style="western"><surname>Rouilly</surname><given-names>V</given-names></name><name name-style="western"><surname>Poss&#233;m&#233;</surname><given-names>C</given-names></name><name name-style="western"><surname>Bertrand</surname><given-names>A</given-names></name><etal/></person-group><article-title>Smoking changes adaptive immunity with persistent effects</article-title><source>Nature</source><year>2024</year><volume>626</volume><issue>8000</issue><fpage>827</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1038/s41586-023-06968-8</pub-id><pub-id pub-id-type="pmid">38355791</pub-id><pub-id pub-id-type="pmcid">PMC10881394</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Saint-Andr&#233; V, Charbit B, Biton A, Rouilly V, Poss&#233;m&#233; C, Bertrand A, et al. Smoking changes adaptive immunity with persistent effects. Nature. 2024;626(8000):827&#8211;35.<pub-id pub-id-type="pmid">38355791</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-023-06968-8</pub-id><pub-id pub-id-type="pmcid">PMC10881394</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C</given-names></name></person-group><article-title>The effect of preoperative smoking and smoke cessation on wound healing and infection in post-surgery subjects: A meta-analysis</article-title><source>Int Wound J</source><year>2022</year><volume>19</volume><issue>8</issue><fpage>2101</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1111/iwj.13815</pub-id><pub-id pub-id-type="pmid">35451193</pub-id><pub-id pub-id-type="pmcid">PMC9705191</pub-id><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retraction-forward" ext-link-type="pmc" xlink:href="PMC11943824"/></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Liu D, Zhu L, Yang C. The effect of preoperative smoking and smoke cessation on wound healing and infection in post-surgery subjects: A meta-analysis. Int Wound J. 2022;19(8):2101&#8211;6.<pub-id pub-id-type="pmid">35451193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/iwj.13815</pub-id><pub-id pub-id-type="pmcid">PMC9705191</pub-id><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retraction-forward" ext-link-type="pmc" xlink:href="PMC11943824"/></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jackson</surname><given-names>KL</given-names></name><name name-style="western"><surname>Devine</surname><given-names>JG</given-names></name></person-group><article-title>The effects of smoking and smoking cessation on spine surgery: A systematic review of the literature</article-title><source>Global Spine J</source><year>2016</year><volume>6</volume><issue>7</issue><fpage>695</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1055/s-0036-1571285</pub-id><pub-id pub-id-type="pmid">27781190</pub-id><pub-id pub-id-type="pmcid">PMC5077710</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Jackson KL 2nd, Devine JG. The effects of smoking and smoking cessation on spine surgery: A systematic review of the literature. Global Spine J. 2016;6(7):695&#8211;701.<pub-id pub-id-type="pmid">27781190</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-0036-1571285</pub-id><pub-id pub-id-type="pmcid">PMC5077710</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khalid</surname><given-names>SI</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>KB</given-names></name><name name-style="western"><surname>Chilakapati</surname><given-names>S</given-names></name><name name-style="western"><surname>Singh</surname><given-names>R</given-names></name><name name-style="western"><surname>Eldridge</surname><given-names>C</given-names></name><name name-style="western"><surname>Mehta</surname><given-names>AI</given-names></name><etal/></person-group><article-title>The impact of smoking cessation therapy on lumbar fusion outcomes</article-title><source>World Neurosurg</source><year>2022</year><volume>164</volume><fpage>e119</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.wneu.2022.04.031</pub-id><pub-id pub-id-type="pmid">35439621</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Khalid SI, Thomson KB, Chilakapati S, Singh R, Eldridge C, Mehta AI, et al. The impact of smoking cessation therapy on lumbar fusion outcomes. World Neurosurg. 2022;164:e119&#8211;26.<pub-id pub-id-type="pmid">35439621</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.wneu.2022.04.031</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohata</surname><given-names>M</given-names></name><name name-style="western"><surname>Nawa</surname><given-names>N</given-names></name><name name-style="western"><surname>Minami</surname><given-names>K</given-names></name><name name-style="western"><surname>Uchida</surname><given-names>T</given-names></name><name name-style="western"><surname>Fujiwara</surname><given-names>T</given-names></name></person-group><article-title>Impact of preoperative intervention for smoking cessation on postoperative length of stay and cost for spine surgery patients: propensity score matching analysis</article-title><source>Anaesth Crit Care Pain Med</source><year>2023</year><volume>42</volume><issue>6</issue><fpage>101270</fpage><pub-id pub-id-type="doi">10.1016/j.accpm.2023.101270</pub-id><pub-id pub-id-type="pmid">37379968</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Ohata M, Nawa N, Minami K, Uchida T, Fujiwara T. Impact of preoperative intervention for smoking cessation on postoperative length of stay and cost for spine surgery patients: propensity score matching analysis. Anaesth Crit Care Pain Med. 2023;42(6):101270.<pub-id pub-id-type="pmid">37379968</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.accpm.2023.101270</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khalid</surname><given-names>SI</given-names></name><name name-style="western"><surname>Eldridge</surname><given-names>C</given-names></name><name name-style="western"><surname>Singh</surname><given-names>R</given-names></name><name name-style="western"><surname>Shanker</surname><given-names>RM</given-names></name><name name-style="western"><surname>MacDonald</surname><given-names>AM</given-names></name><name name-style="western"><surname>Chilakapati</surname><given-names>S</given-names></name><etal/></person-group><article-title>The impact of smoking and smoking cessation interventions on outcomes following single-level anterior cervical discectomy and fusion procedures</article-title><source>Clin Neurol Neurosurg</source><year>2022</year><volume>219</volume><fpage>107319</fpage><pub-id pub-id-type="doi">10.1016/j.clineuro.2022.107319</pub-id><pub-id pub-id-type="pmid">35777181</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Khalid SI, Eldridge C, Singh R, Shanker RM, MacDonald AM, Chilakapati S, et al. The impact of smoking and smoking cessation interventions on outcomes following single-level anterior cervical discectomy and fusion procedures. Clin Neurol Neurosurg. 2022;219:107319.<pub-id pub-id-type="pmid">35777181</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clineuro.2022.107319</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>